(Hypertension. 1996;27:346-353.)
© 1996 American Heart Association, Inc.
Articles |
Evidence for a Multifactorial Process Involved in the Impaired Flow Response to Nitric Oxide in Hypertensive Patients With Endothelial Dysfunction
From the Department of Medicine, Division of Cardiology, Pulmonary Diseases and Angiology, and the Department of Pharmacology (D.J.H.), Heinrich-Heine-University Düsseldorf, Germany.
Abstract The assessment of endothelial function in hypertensive patients receiving acetylcholine has revealed conflicting results. Whether an impaired flow response to acetylcholine is explained solely by a diminished endothelial synthesis of nitric oxide (NO) remains unclear as yet. In the present study, we tested the hypothesis that mechanisms other than reduced NO synthesis contribute to the hypertension-associated impairment of endothelium-dependent vasodilation. Therefore, the dilatory response to endogenous and exogenous NO was measured in resistance arteries and cutaneous microvessels in the forearm circulation of 12 normotensive individuals and 17 hypertensive patients. In addition, the overall dilatory capacity was assessed by peak flow during reactive hyperemia after 3 minutes of ischemia. Forearm blood flow was quantified by venous occlusion plethysmography at rest, during application of the NO donor sodium nitroprusside, and during stimulation of endogenous NO synthesis by acetylcholine and bradykinin. Blood flow velocity in the cutaneous microvasculature was measured with laser-Doppler flowmetry in parallel. Resting forearm flow was comparable in both groups (3.1±0.2 and 3.4±0.2 mL·min-1·100 mL-1 tissue), whereas blood pressure and thus peripheral vascular resistance was significantly elevated in hypertensive compared with normotensive subjects. Hyperemic peak flow was significantly blunted in hypertensive patients. Sodium nitroprusside, acetylcholine, and bradykinin increased flow in a dose-dependent manner to a comparable extent in the control group (13.3±0.8, 13.6±1.3, and 14.6±0.7 mL·min-1·100 mL-1 tissue, respectively). In contrast, in hypertensive patients maximum increase in resting flow was significantly reduced (sodium nitroprusside, -36%; acetylcholine, -44%; and bradykinin, -56%). The flow response after stimulation of endogenous NO synthesis by bradykinin was significantly more blunted compared with that of exogenous NO after application of sodium nitroprusside. In the cutaneous microvasculature, bradykinin-induced increases in blood flow velocity were selectively impaired in hypertensive patients, whereas flow response to acetylcholine was preserved. Thus, we conclude that in arterial hypertension endothelium-dependent, NO-mediated dilation of resistance arteries and cutaneous microvessels of the forearm vasculature is heterogeneously impaired, depending on the type of endothelial receptor stimulated. Furthermore, the present data suggest that in hypertensive patients the impairment of NO-dependent dilation of resistance arteries is caused by at least three different mechanisms: (1) a reduced endothelial synthesis of NO due to either a disturbed signal-transduction pathway and/or a reduced activity of NO synthase, (2) an accelerated NO degradation within the vessel wall, and (3) alterations in the vessel architecture resulting in an overall reduced dilatory capacity of resistance arteries.
Key Words: vascular diseases • nitric oxide • endothelium • microcirculation • acetylcholine • arterial hypertension • bradykinin
This article has been cited by other articles:
 |
|
 |
|
  B. Almeida, S. Buttner, S. Ohlmeier, A. Silva, A. Mesquita, B. Sampaio-Marques, N. S. Osorio, A. Kollau, B. Mayer, C. Leao, et al. NO-mediated apoptosis in yeast J. Cell Sci., September 15, 2007; 120(18): 3279 - 3288. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Kimura, D. A. Low, D. M. Keller, S. L. Davis, and C. G. Crandall Cutaneous blood flow and sweat rate responses to exogenous administration of acetylcholine and methacholine J Appl Physiol, May 1, 2007; 102(5): 1856 - 1861. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Rassaf, L. W. Poll, P. Brouzos, T. Lauer, M. Totzeck, P. Kleinbongard, P. Gharini, K. Andersen, R. Schulz, G. Heusch, et al. Positive effects of nitric oxide on left ventricular function in humans Eur. Heart J., July 2, 2006; 27(14): 1699 - 1705. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Grahame-Clarke, N. N. Chan, D. Andrew, G. L. Ridgway, D. J. Betteridge, V. Emery, H. M. Colhoun, and P. Vallance Human Cytomegalovirus Seropositivity Is Associated With Impaired Vascular Function Circulation, August 12, 2003; 108(6): 678 - 683. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Rassaf, P. Kleinbongard, M. Preik, A. Dejam, P. Gharini, T. Lauer, J. Erckenbrecht, A. Duschin, R. Schulz, G. Heusch, et al. Plasma Nitrosothiols Contribute to the Systemic Vasodilator Effects of Intravenously Applied NO: Experimental and Clinical Study on the Fate of NO in Human Blood Circ. Res., September 20, 2002; 91(6): 470 - 477. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Kelm Flow-mediated dilatation in human circulation: diagnostic and therapeutic aspects Am J Physiol Heart Circ Physiol, January 1, 2002; 282(1): H1 - H5. [Full Text] [PDF]
|
|
|
|
 |
|
 K. M. Gauthier and N. J. Rusch Rat Coronary Endothelial Cell Membrane Potential Responses During Hypertension Hypertension, January 1, 2001; 37(1): 66 - 71. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Preik, M. Kelm, P. Rosen, D. Tschope, and B. E. Strauer Additive Effect of Coexistent Type 2 Diabetes and Arterial Hypertension on Endothelial Dysfunction in Resistance Arteries of Human Forearm Vasculature Angiology, July 1, 2000; 51(7): 545 - 554. [Abstract] [PDF]
|
|
|
|
 |
|
 I. Tritto and G. Ambrosio Spotlight on microcirculation: an update Cardiovasc Res, June 1, 1999; 42(3): 600 - 606. [Full Text] [PDF]
|
|
|
|
|
|
G. Dell'Omo, L. Ferrini, M. Morale, F. De Negri, E. Melillo, F. Carmassi, and R. Pedrinelli Acetylcholine-Mediated Vasodilatation and Tissue-type Plasminogen Activator Release in Normal and Hypertensive Men Angiology, April 1, 1999; 50(4): 273 - 282. [Abstract] [PDF]
|
|
|
|
|
|
M. Kelm, H. Preik-Steinhoff, M. Preik, and B. E. Strauer Serum nitrite sensitively reflects endothelial NO formation in human forearm vasculature: evidence for biochemical assessment of the endothelial L-arginine-NO pathway Cardiovasc Res, March 1, 1999; 41(3): 765 - 772. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Laine, M. J. Knuuti, U. Ruotsalainen, T. Utriainen, V. Oikonen, M. Raitakari, M. Luotolahti, O. Kirvela, P. Vicini, C. Cobelli, et al. Preserved Relative Dispersion but Blunted Stimulation of Mean Flow, Absolute Dispersion, and Blood Volume by Insulin in Skeletal Muscle of Patients With Essential Hypertension Circulation, June 2, 1998; 97(21): 2146 - 2153. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Cardillo and J. A Panza Impaired endothelial regulation of vascular tone in patients with systemic arterial hypertension Vascular Medicine, May 1, 1998; 3(2): 138 - 144. [Abstract] [PDF]
|
|
|
|
|
|
K. M. Gauthier-Rein and N. J. Rusch Distinct Endothelial Impairment in Coronary Microvessels from Hypertensive Dahl Rats Hypertension, January 1, 1998; 31(1): 328 - 334. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Benjamin and J. Vane Nitric Oxide and Hypertension Circulation, September 15, 1996; 94(6): 1197 - 1198. [Full Text]
|
|